Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection

J. Virol. Methods

R. P. Singh, Jolanta Kurz, Gilles Boiteau · Journal of Virological Methods · 1996 · 2.6K citations

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Marie‐Hélène Mayrand, Eliane Duarte‐Franco, Isabel Rodrigues et al. · New England Journal of Medicine · 2007 · 1.1K citations

Medicine, Gynecology, Oncology +16

The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

Michelle J. Khan, Philip E. Castle, Attila T. Lörincz et al. · JNCI Journal of the National Cancer Institute · 2005 · 1.1K citations · Full text

Medicine, Oncology, Pathology +16

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

Chris J.L.M. Meijer, Johannes Berkhof, Philip E. Castle et al. · International Journal of Cancer · 2008 · 695 citations · Full text

Medicine, Gynecology, Oncology +17

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

NWJ Bulkmans, Johannes Berkhof, Lawrence Rozendaal et al. · The Lancet · 2007 · 645 citations

Medicine, Gynecology, Oncology +17